Reviewed by Peptide Treatments Medical Advisory Board
Cartalax: Research & Evidence
Early-Stage ResearchPublished research, clinical trial data, and evidence grading for Cartalax across studied indications.
Back to Cartalax overviewResearch Summary
Cartalax has zero PubMed-indexed human studies, zero RCTs, and no Western clinical trials. All efficacy claims derive from Russian-language animal studies that have not been independently replicated. Established cartilage supplements like glucosamine and chondroitin have more human evidence, though their efficacy also remains debated.
Evidence by Indication (2 indications)
| Indication | Tier | Trials | Summary |
|---|---|---|---|
| Osteoarthritis | Tier D | 0 | No human trials exist; rodent studies report reduced cartilage degeneration but remain unverified |
| Cartilage repair | Tier D | 0 | Animal data suggests chondrocyte effects but no human translation has been attempted |
Graded using our evidence tier methodology.
Research Gap Score /10
Higher score = larger gap between therapeutic potential and available clinical evidence.